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Abstract In recent years, functional genomics approaches combining genetic information with bulk
RNA-sequencing data have identified the downstream expression effects of disease-associated
genetic risk factors through so-called expression quantitative trait locus (eQTL) analysis. Single-cell
RNA-sequencing creates enormous opportunities for mapping eQTLs across different cell types and
in dynamic processes, many of which are obscured when using bulk methods. Rapid increase in
throughput and reduction in cost per cell now allow this technology to be applied to large-scale
population genetics studies. To fully leverage these emerging data resources, we have founded the
single-cell eQTLGen consortium (sc-eQTLGen), aimed at pinpointing the cellular contexts in which
disease-causing genetic variants affect gene expression. Here, we outline the goals, approach and
potential utility of the sc-eQTLGen consortium. We also provide a set of study design considerations
for future single-cell eQTL studies.
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Interindividual variation needs to
be studied at the single-cell level
Genetic variants, most commonly single nucleo-
tide polymorphisms (SNPs), can contribute to
disease in a plethora of ways. In monogenic dis-
eases, one single variant is sufficient to result in
a disease phenotype. In complex diseases, tens
to hundreds of variants each independently con-
tribute to disease risk and an accumulation of
risk alleles – often in combination with specific
environmental exposures – is required to
develop the disease phenotype. The overwhelm-
ing evidence showing enrichment of disease-
associated variants in regulatory regions sug-
gests that regulation of gene expression is likely
a dominant mediator for disease risk. Expression
quantitative trait loci (eQTL) analysis is com-
monly used for linking disease risk-SNPs to
downstream expression effects on local (cis) or
distal (trans) genes. Large-scale eQTL efforts
such as GTEx (GTEx Consortium, 2017), Psy-
chENCODE (Wang et al., 2018), ImmVar
(Ye et al., 2014), BLUEPRINT (Chen et al.,
2016), CAGE (Lloyd-Jones et al., 2017), and
eQTLGen (Võsa, 2018) have proven highly
valuable to identify downstream transcriptional
consequences. All these efforts together lead to
ever growing sample sizes that now allow us to
start identifying both cis- and trans-eQTLs.
An important next step is to precisely define
the cellular contexts in which disease risk-SNPs
affect gene expression levels. This will help to
better understand the molecular and cellular
mechanisms by which disease risk is conferred
and to inform therapeutic strategies. This needs
to be done as recent analyses have shown that
many eQTL effects are tissue
(GTEx Consortium, 2017; Fu et al., 2012) and
cell type-specific (Brown et al., 2013;
Fairfax et al., 2012). Additionally, many eQTLs
are conditional, and only revealed after specific
stimuli that, for example, change the activation
or differentiation of specific cell types (Ye et al.,
2014; Cuomo et al., 2020). Beyond the ability
to annotate individual disease associations, cell
type-specific eQTLs have been shown to be
strongly enriched for heritability across complex
traits (Hormozdiari et al., 2018). Sorting
(Fairfax et al., 2012; Ishigaki et al., 2017) and
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2015; Venet et al., 2001) of cell types from
bulk samples have been used to uncover con-
text-specificity of eQTLs. However, these meth-
ods are biased towards known cell types defined
by a limited set of marker genes
(Zhernakova et al., 2017), are of limited use for
less abundant cell types, and do not capture any
heterogeneity within a sorted population. In
contrast, single-cell RNA-sequencing (scRNA-
seq) enables the simultaneous and unbiased
estimation of cellular composition and cell type-
specific gene expression (van der Wijst et al.,
2018a), and is particularly well positioned to
investigate rare cell types (Villani et al., 2017).
As opposed to using bulk data, single-cell data
allows us to also link genetics to phenomena
such as cell-to-cell expression variability
(Cuomo et al., 2020), cell type heterogeneity
(Donovan et al., 2019), and gene regulatory
network differences (van der Wijst et al.,
2018a). As such, single-cell analyses in a popula-
tion-based setting will likely become mainstream
in the next few years. However, we envision that
most scientific value will be obtained by unifying
these efforts. Additionally, to utilize the afore-
mentioned developments in the single-cell field
most efficiently and effectively, a coordinated
effort from multiple research groups is urgently
needed.
Here we introduce the single-cell eQTLGen
consortium (sc-eQTLGen), a large-scale, interna-
tional collaborative effort that has been set up
to identify the upstream interactors and down-
stream consequences of disease-related genetic
variants in individual immune cell types (https://
eqtlgen.org/single-cell.html, Figure 1). In this
consortium we will attain a sufficiently large sam-
ple size to have the statistical power to unbias-
edly identify cell type-specific effects on both cis
and trans genes. Moreover, we aim to
Population cohort:
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ment, gene expression imputation
Consistent eQTL analysis per cohort,
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Figure 1. Set-up of the single-cell eQTLGen (sc-eQTLGen) consortium. The sc-eQTLGen consortium combines an individual’s genetic information with
single-cell RNA expression (scRNA-seq) data of peripheral blood mononuclear cells (PBMCs) in order to identify effects of genetic variation on
downstream gene expression levels (eQTLs) and to enable reconstruction of personalized gene regulatory networks. Right panel is adapted from
van der Wijst et al. (2018b).
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reconstruct context-specific gene regulatory net-
works (GRNs) by combining single-cell and bulk
RNA-seq datasets for increased resolution. We
expect the results of sc-eQTLGen to have an
impact in a number of areas including the priori-
tization of disease-risk genes, the prediction of
drug efficacy and the reconstruction of personal-
ized GRNs.
Integration of sc-eQTLGen within
the scientific landscape
Large numbers of single cell expression profiles
from many individuals are required to reach our
goals. The accessibility and clinical relevance of
peripheral blood mononuclear cells (PBMCs)
have made them the most studied cell types in
current population-based scRNA-seq datasets.
Therefore, to have such datasets from the same
tissue type readily available, we have chosen to
focus on PBMCs. It also allows for continuation
of the knowledge acquired through the eQTL-
Gen consortium, which performed the largest
eQTL meta-analysis to date using whole blood
bulk gene expression data of over 30,000 indi-
viduals to reveal the influence of genetics on
gene expression (Võsa, 2018). The sc-eQTLGen
consortium now allows us to take the next step
by systematically assessing the cell types and
contexts in which the eQTL effects manifest.
Beyond resolving the influence of genetics on
individual genes, the consortium will also take
advantage of the unique features of scRNA-seq
data to learn the directionality of GRNs and
uncover how genetics is affecting co-expression
relationships (van der Wijst et al., 2018a). We
expect that the infrastructure and best practices
developed within sc-eQTLGen can serve as a
basis for studying population genetics at the sin-
gle-cell level in solid tissues in the future.
Other large-scale efforts such as the Human
Cell Atlas (HCA) (Regev et al., 2017) or Lifetime
FET flagship consortium (https://lifetime-fetflag-
ship.eu) mainly focus on mapping all cells of the
human body or a disease context in a limited
number of individuals. The sc-eQTLGen consor-
tium will complement those efforts by putting a
unique focus on deciphering the impact of
genetic variation on gene expression and its reg-
ulation. Different to experimental designs that
aim to generate an extensive map on a low num-
ber of individuals, we require larger numbers of
individuals, whereas the number of cells per indi-
vidual can be lower. This will enable the accurate
capture of both the genetic variation and the
cell type heterogeneity. By building on the data
and harmonized cell type annotations generated
within the HCA, our results will be easily trans-
ferable to other datasets as well. We will share
best practices of the HCA consortium with
regard to data acquisition, analysis and report-
ing. We also share standards for open science
and the infrastructure and legal frameworks for
data sharing while accounting for the privacy
issues specific to genetic, health record and
demographic information.
Single cell eQTL analysis: the new
era of population genetics
The practice of identifying eQTLs is shifting from
bulk to single-cell analyses. Considering only its
ability to identify eQTLs, scRNA-seq data has a
lower statistical power compared to bulk RNA-
seq data on the same number of donors
(Cuomo et al., 2020; Sarkar et al., 2019), likely
due to increased sparsity of the single-cell data.
Nevertheless, there are several clear benefits of
single-cell over bulk expression data for QTL
analysis. First, scRNA-seq data enables the
simultaneous estimation of the composition and
expression profiles of discrete cell populations
including cell types and their activation states
(van der Wijst et al., 2018a; Figure 2). Second,
scRNA-seq data provides a flexible, unbiased
approach that has increased resolution to define
BA C
Identify distinct cell types Trace cell type lineages Identify cell subtypes
Figure 2. scRNA-seq data offers increased flexibility in the eQTL analysis strategy over
bulk RNA-seq data. Using scRNA-seq data for eQTL mapping offers a number of
advantages over bulk RNA-seq based approaches, of which the flexibility in analysis strategy
is a major one. (A) From single cell data, individual cell types can be identified and we can
map eQTLs for each of these. (B) Alternatively, lineages based on either knowledge of cell
developmental lineages or through pseudo-time based approaches can be constructed. By
positioning cells across a trajectory dynamic changes in the allelic effects on gene
expression levels as a function of trajectory position can be integrated. (C) Finally, as the
discoveries of new cell subtypes are made or cell type definitions are being refined, the
analysis can be revisiting by re-classifying cells and determining how the genetic effects on
gene expression vary on these new annotations.
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Box 1. Guidelines for creating a population-based single-cell cohort.
Even though a single-cell eQTL dataset has less discovery power than an equal-sized bulk RNA-seq eQTL dataset (6.9 fold dif-
ference based on the lowest correlation that led to the identification of a significant eQTL from single-cell [van der Wijst et al.,
2018a] vs bulk RNA-seq data [Zhernakova et al., 2017]), it does provide insights that cannot easily be extracted from bulk
data. For example, single-cell data allows for the unbiased detection of cell type- and context-dependent eQTLs and has more
power to detect co-expression QTLs (van der Wijst et al., 2018a). This makes population-based single-cell datasets a valuable
addition to bulk-based datasets for studying the effects of genetic variation on gene expression and its regulation (van der
Wijst et al., 2018a; Kang et al., 2018). In comparison to ‘standard’ single-cell datasets, generating such population-based sin-
gle-cell datasets require some additional aspects to be taken into account.
First of all, the genetic information that is available for each of the individuals in such cohorts can be used to demultiplex pools
of multiple individuals within the same sample. This approach allows to properly randomize experiments, while also significantly
reducing cost and confounding effects (Kang et al., 2018; Bycroft et al., 2018). This genetic information can either be effi-
ciently generated using genotype arrays (Marchini and Howie, 2010) in combination with imputation-based approaches
(Xu, 2019), or extracted from the scRNA-seq data itself (Bycroft et al., 2018; McCarthy et al., 2016). Within the consortium
all reads will be aligned to the GRCh38/hg38 reference genome and genotypes will be imputed using the Haplotype Reference
Consortium reference panel (Gravel et al., 2011). The basic principle behind genetic multiplexing is that enough transcripts
harboring SNPs are expressed and detected in each single cell such that cells can be accurately assigned to the donor of origin.
Furthermore, as the number of multiplexed individuals increases, the probability that a droplet harbors multiple cells from dif-
ferent individuals increases, thus allowing the detection of multiplets using genetic information. This enables the overloading of
cells into standard droplet-based workflows and overall reduction of cost per cell up to about 10-fold (https://satijalab.org/
costpercell). As the cost of sequencing and the background multiplet rate reduce, the benefits of multiplexing increase. We
anticipate that future workflows will allow for even higher throughput.
Secondly, accounting for ethnicity variation and population stratification will be required when single-cell data of diverse popu-
lations are being analyzed. It is known that a different genetic architecture exists between different populations. Nevertheless,
practical considerations have limited the majority of eQTL studies to cohorts of European origin. As an undesirable conse-
quence of this bias in population representation, certain variants may not have been detected before (Carlson et al., 2013) or
the effect sizes and associated polygenic risk scores based on the European population may not be translatable to other popu-
lations (Martin et al., 2017; Sirugo et al., 2019). Therefore, inclusion of datasets from different ethnic populations will help
reduce long-standing disparities in genetic studies and has many analytical advantages (Wojcik et al., 2019; Hsiao et al.,
2010). For example, the increased genotype frequency diversity will enhance the range over which gene expression varies, and
thereby, will further increase statistical power. To implement multi-population sc-eQTL analysis, several challenges have to be
addressed. Handling data from populations with different levels of population genetic properties such as LD structure, related-
ness and multiple genetic origins that result in the presence of genetic covariance remains important and requires appropriate
adjustments to avoid spurious signal and to manage the bias in estimating genetic cis- and trans-effects (Zhou and Stephens,
2012; Mandric, 2019). This is particularly important when differences in cohort-specific genetic characteristics are enhanced
such as when family-based and unrelated cohorts or cohorts of different ancestries are analyzed. Failing to account for these
effects affects the accuracy of mapping and results in false positives.
Finally, studying genetic variation at the single-cell level adds some extra requirements for the number of cells per individual
and the number of individuals to be included in the study. The number of cells per individual will mainly define for which cell
types in a heterogeneous sample such as PBMCs eQTL and co-eQTL analyses can be performed. In contrast, the number of
individuals will mainly define the number of genetic variants for which effects on gene expression can be confidently assessed.
A recent analysis showed that, with a fixed budget, the optimal power for detecting cell type-specific eQTLs is obtained when
the number of reads is spread across many individuals119. Even though a lower sequencing depth per cell results in a lower
accuracy of estimating cell type-specific gene expression levels, many more individuals and cells per individual can be included
for the same budget. As a result, the optimal experimental design with a fixed budget provides up to three times more power
than a design based on the recommended sequencing depth of 50,000 reads per cell (for 10X Genomics scRNA-seq). In con-
trast, for co-eQTL analysis there is a different trade-off between sequencing depth, number of individuals and number of reads
per cell; while for eQTL analysis gene expression levels among cells of the same cell type can be averaged, for co-eQTL analysis
you cannot as this would prohibit you from calculating a gene-gene correlation per individual. Therefore, for co-eQTLs the
sequencing depth will be a major limiting factor that determines the number of genes for which you can confidently calculate
gene-gene correlations. Altogether, depending on the goal of your study, the optimal balance between sequencing depth and
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cell states along continuous dynamic processes
in which the eQTL effects manifest themselves
(Cuomo et al., 2020). Third and fourth, single-
cell data allows estimating the variability in gene
expression across individual cells
(Brennecke et al., 2013; Eling et al., 2018),
which could be used to improve mean estima-
tions for eQTL analysis. At the same time, the
single-cell nature now also enables us to look at
the effect of genetic variation on transcriptomic
traits other than average gene expression level,
such as dispersion QTLs that alter the variance
independently of the mean expression
(Sarkar et al., 2019) or cell type proportion
QTLs (Kang et al., 2018), providing a new angle
on how genetic variation may impact disease
pathogenesis. Fifth, the large number of obser-
vations per individual (i.e. cells) enable the gen-
eration of personalized co-expression networks,
which vastly reduces the number of individuals
required to identify SNPs altering co-expression
relationships (i.e. co-expression QTLs [van der
Wijst et al., 2018a]). Finally, and paradoxically,
is the potential benefit of lower experimental
costs compared to bulk experiments on sorted
cells: such experiments require a library to be
generated for each sorted population, whereas
a single scRNA-seq library of just one sample
contains all this information and can easily be
multiplexed across multiple individuals
(Kang et al., 2018).
So far, only a limited number of papers have
performed eQTL analysis using scRNA-seq data
(Cuomo et al., 2020; van der Wijst et al.,
2018a; Sarkar et al., 2019; Kang et al., 2018).
In the earliest single-cell eQTL studies, bulk-
based eQTL analysis approaches, such as Spear-
man rank correlation (Heap et al., 2009;
Stranger et al., 2007) and linear regression
(Michaelson et al., 2009; Stranger et al.,
2005), were applied to the average expression
level of all cells from a particular cell type per
individual. However, the underlying assumptions
of these bulk-based approaches may not be
applicable to scRNA-seq data. Therefore, these
bulk-based methods will lose statistical power
when applied to scRNA-seq data, because of
the inflation of zero values (i.e. sparsity). More
recently, single-cell-specific eQTL methods have
been developed that, for example, take into
account zero-inflated gene expression
(Sarkar et al., 2019; Hu and Zhang, 2018) or
take advantage of pseudotime (i.e. statistically
inferred time from snapshot data) to increase
the resolution by which response-/differentia-
tion-associated eQTLs (dynamic eQTLs, i.e.
eQTLs that dynamically change along pseudo-
time) can be identified (Cuomo et al., 2020).
Instead of averaging gene expression levels
across all cells from a particular cell type, some
of these approaches look at the fraction of zero
expression and the non-zero expression sepa-
rately for each gene (Hu and Zhang, 2018).
Other approaches take dynamic pseudotime-
defined instead of statically-defined cell types
into consideration for the eQTL analysis
(Cuomo et al., 2020). This latter approach was
shown to uncover hundreds of new eQTL var-
iants during iPSC differentiation that had not
been detected when static differentiation time
points would have been used (Cuomo et al.,
2020). In line with this, we expect that some of
these methodological advances, as opposed to
bulk-based approaches, will further improve the
power and resolution of single-cell eQTL analy-
sis. However, there are two initial challenges
that need to be carefully addressed for single-
cell eQTL mapping: firstly, the normalization of
data to remove technical variation in sequencing
depth per cell, while avoiding the removal of
biological variation; and secondly, the identifica-
tion or classification of a cell into a cell type or
state.
During library preparation and sequencing,
technical and stochastic factors will lead to varia-
tion in cell-to-cell sequencing depth. However,
simply normalizing to equal sequencing depth
per cell will remove important biological varia-
tion – for example a CD4+ T cell is expected to
have lower RNA contents than a plasma B cell.
Therefore, we need to employ normalization
strategies that can account for traditional batch
effects, such as sample run or sequencing lane,
while retaining biological differences
(Bacher et al., 2017; Hafemeister and Satija,
2019).
Once normalized, each cell needs to be accu-
rately annotated into a cell type and/or cell state
number of individuals and cells per individual will be different. By the end of 2020, the sc-eQTLGen consortium will provide
standardized pipelines and guidelines for single-cell population genetics studies.
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to maximize the statistical power to detect cell
type-specific eQTLs. We encourage the use of
individual cell classification approaches, rather
than cluster-labeling methods. Clustering
approaches are powerful ways of identifying a
subpopulation of cells that share similar expres-
sion levels. However, while most cells placed in a
specific cluster will likely be the same cell type,
clusters can also contain alternative cell types.
Labeling all cells in a cluster based on a high
percentage of the expression of a canonical
marker(s) will therefore lead to the incorrect
classification of some cells (Alquicira-
Hernández et al., 2018). To acquire a reliable
classification model, large scRNA-seq datasets
from various contexts are required. Such data-
sets have been collected within large-scale
efforts such as our consortium and the HCA. We
expect these will help to develop a gold stan-
dard classification model that can classify each
cell independently. This will ensure a higher
accuracy in cell labeling and thus will maximize
power to detect cell type-specific effects.
After solving these challenges, eQTLs can be
mapped by either averaging the normalized
expression levels on a per gene, per cell type,
per individual basis. Alternatively, each cell from
an individual can be taken as a repeated mea-
sure which can then be used to fit a statistical
model to all cells, while including a random
effect of the individual.
Instead of using observational studies, eQTLs
could also be identified through experimental
approaches that use single cells as individual
units of experimentation (Gasperini et al.,
2019). Sample multiplexing (see Box 1) can be
combined with experimental perturbation to
more efficiently characterize the genetic archi-
tecture of gene expression. For example, syn-
thetic genetic perturbations with CRISPR/Cas9
may allow precise control of the expression lev-
els of target gene regulators enabling the valida-
tion of detected trans-eQTLs and the
establishment of upper and lower bounds of
trans effects. Encoding environmental and
genetic perturbations across large population
cohorts also enables new designs for studying
genetic interactions, both gene-by-environment
and gene-by-gene (epistasis). Historically, char-
acterizing these effects in human cells has been
plagued by the lack of power and the suscepti-
bility to technical confounding of bulk experi-
ments. Recent work that knocked out ~150
regulators in primary human T cells of nine
donors illustrates a proof of concept of how sin-
gle-cell sequencing across individuals can be
combined with experimental perturbations to


























Figure 3. Reconstruction of personalized gene regulatory networks. Individual and cell-type specific scRNA-seq
data will be used to construct personalized gene regulatory networks. Some single cell datasets allow for the
inference of trajectories, for instance in response to a stimulus. These can be used as input to dynamic models to
infer causal (directed) interactions. Steady state datasets, characterized by cell type clusters can be analyzed with
models that exploit co-expression, prior networks or cell type-specific reference scATAC-seq datasets in
combination with sequence motifs to infer directed transcription factor-target relations. Topological comparison
between personalized networks of groups of individuals can reveal coordinated differences, for instance the
change of connectivity in densely connected modules, change of connectivity of hub genes or changes of module
membership of individual genes.
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Figure 4. Overview of the sc-eQTLGen proposed federated approach. sc-eQTLGen aims to identify the
downstream consequences and upstream interactors of gene expression regulation. To increase the resolution
and power of this analysis, datasets of multiple cohorts need to be combined while taking privacy issues into
account. This will be done using a federated approach in which we will first harmonize all preprocessing and
quality control (QC) steps across cohorts. Subsequently, shared gene expression matrices will be normalized and
cell types will be classified based on a trained reference dataset (e.g. Immune Cell Atlas (ICA)). Any cells that
Figure 4 continued on next page
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Another promising avenue that has become
available in recent years to gain increased
insights in the link between genetics and dis-
ease, is through the use of spatial transcriptom-
ics technologies, including MERFISH, seqFISH+,
Slide-seq and 10x Visium (Burgess, 2019;
Maynard et al., 2020). While for PBMCs this
approach may not be applicable, in solid tissues
and organs this extra layer of spatial information
is extremely valuable. For example, it can help
to disentangle trans-eQTL interactions that are
modulated through cell-cell communication (e.g.
a SNP affects ligand expression in one cell type,
and thereby affects downstream receptor signal-
ing in a second cell type). Despite not having
this spatial information available in PBMCs,
other approaches that consider receptor-ligand
expression pairs do provide insights in potential
cell-cell interactions. These approaches have
been successfully applied before to uncover how
the ligand expression in one cell type can affect
the frequency (Smillie et al., 2019) or the down-
stream signaling (Arneson et al., 2018) of
another cell type expressing the corresponding
receptor.
Single cell GRN reconstruction:
taking eQTLs one step further
In the case of complex diseases, it is not the dis-
ruption of a single gene that causes the disease
phenotype. In fact, hundreds of variants can con-
tribute to the disease and converge into just a
few key disrupted regulatory pathways
(Westra et al., 2013; Fagny et al., 2017).
Therefore, for a better disease understanding
and to take eQTLs one step further, one has to
look beyond the disruption of individual genes
and determine how the interaction of genes
changes based on cell type (Battle et al.,
2014; GTEx Consortium, 2017; Westra et al.,
2015; Knowles et al., 2017), environment
(Favé et al., 2018; van der Wijst et al., 2018b)
and an individual’s genetic makeup
(Zhernakova et al., 2017; van der Wijst et al.,
2018a). The sc-eQTLGen consortium will do so
by reconstructing personalized, cell type-specific
GRNs (La Manno et al., 2018; Figure 3). The
unique features of scRNA-seq data, among
which the inference of pseudotime and RNA
velocity (i.e. the ratio between spliced and
unspliced mRNA that allows prediction of the
future state of a cell) (Qiu, 2018), enable learn-
ing the directionality of network connections
(Fiers et al., 2018). We expect that such person-
alized GRNs will help explain for example differ-
ences in interindividual drug responses, and
thereby, will aid in precision medicine in the
future.
Reconstruction of GRNs from single cell data
reviewed in Raj et al. (2006) is complicated by
the sparsity of the data as a consequence of the
stochasticity underlying gene expression
(Chen and Mar, 2018) and dropouts, i.e. genes
that are not detected in some cells as a conse-
quence of technical limitations (Jackson et al.,
2019). This sparsity leads to lower correlation
estimates that obscure the identification of true
edges in the GRNs. Several solutions have been
developed to overcome this problem, including
the implementation of prior information
(Aibar et al., 2017; Andrews and Hemberg,
2018), gene expression imputation (Aibar et al.,
2017; Iacono et al., 2019) and usage of alterna-
tive measurements of correlation
(Skinnider et al., 2019; Budden et al., 2014).
Firstly, prior information encoded in the DNA
sequence can be used to overcome these com-
plications (Angermueller et al., 2017;
Angelini and Costa, 2014). Such priors on regu-
latory interactions can be derived from, for
example, ChIP-seq data (Miraldi et al., 2019),
ATAC-seq data (Qin et al., 2014), spatial infor-
mation (Burgess, 2019; Maynard et al., 2020)
or from perturbation experiments (Gate, 2019;
Aibar et al., 2017). Implementation of such pri-
ors was shown to improve bulk GRN reconstruc-
tion (Qin et al., 2014; Ghanbari et al., 2015;
Azizi et al., 2018), and similarly, it is expected
to also improve GRNs reconstructed from sin-
gle-cell data (Aibar et al., 2017; Andrews and
Figure 4 continued
cannot be classified using this trained classifier, representing new cell types or previously unknown cell states, can
then be manually annotated based on marker genes, and then be used to further train the classifier. Each cohort
will then separately perform a cis- and trans-eQTL and co-expression QTL analysis using their genotype and
expression matrix, while using appropriate statistical models to account for effects such as gender, population
structure and family-relatedness that can alter the genotype-expression relationship in a cohort-specific manner.
The summary statistics will be shared and analyzed in one centralized place. Finally, these results will be used for
reconstruction of personalized and context-specific gene regulatory networks. Bottom panel is reproduced from
Võsa (2018).
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Hemberg, 2018). However, caution is warranted
when using this information, as their effect on
GRN reconstruction depends on the quality of
these data priors (Siahpirani and Roy, 2017;
Simpson, 1951) and priors derived from bulk
data may not hold true at the single-cell level
(Buenrostro et al., 2015). Recent technological
advances enable studying chromatin accessibility
(Lareau et al., 2019; Hayashi et al., 2018) and
expression of enhancers RNAs (Kouno et al.,
2019; Lin et al., 2016) at the single cell level,
which will make it possible to implement single-
cell derived priors in GRN reconstruction in the
future, though these quantifications come with
their own limitations and challenges.
Secondly, gene expression imputation may
be used to restore the underlying correlation
structure. However, current gene expression
imputation methods become more unreliable as
the dropout rates increase (Iacono et al., 2019;
Skinnider et al., 2019). After gene expression
imputation, more network edges are identified,
but with a higher chance of detecting false posi-
tives (Aibar et al., 2017; Iacono et al., 2019).
Nevertheless, by combining prior information
with imputation, GRN reconstruction can be
improved both in the bulk (Qin et al., 2014) and
single cell setting (Aibar et al., 2017). For exam-
ple, one can replace transcription factor expres-
sion with inferred transcription factor activities
based on the collective expression patterns of
their target genes or take advantage of cross-
omics relationships (Stoeckius et al., 2017).
Finally, alternative correlation measures are
being explored to overcome the complications
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Figure 5. Deliverables of the single-cell eQTLGen consortium in relation to their future clinical implications. (A) In the coming three years the sc-
eQTLGen consortium aims to deliver the following: i) standardized pipelines and guidelines for single-cell population genetics studies (2020); ii) cell
type classification models for PBMCs (2020); iii) summary statistics of cis- and trans-eQTLs, co-expression QTLs, cell count QTLs and variance QTLs
(2021); iv) reconstruction of personalized, cell type-specific gene regulatory networks (2022). (B) These efforts of the consortium will lead to the (1)
identification of disease-associated cell types and (2) key disease-driving genes, which together will aid (3) the implementation of personalized
medicine and the development of new therapeutics that take all this information into account (cell type- and genotype-specific treatments). Panel B2 is
adapted from van der Wijst et al. (2018b).
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measures of proportionality (Budden et al.,
2014) and by calculating the correlations on
measures other than the normalized expression
counts (Skinnider et al., 2019). For example,
Z-scores of the gene expression distributions of
highly similar cells have been used to calculate
the co-expression relationships. This approach
could reveal the true correlation structure that
was otherwise hidden by technical artifacts
(Skinnider et al., 2019). In addition to these
computational tools, technological advances,
such as single-cell multi-omics approaches
(Cao et al., 2018; Moignard et al., 2015) and
improved experimental protocols, are expected
to alleviate these complications. Moreover,
being able to assess multiple layers of informa-
tion within the same cell, e.g. chromatin accessi-
bility, DNA methylation, gene and protein
expression, opens unique opportunities for
developing new methodology for GRN recon-
struction and validation. Altogether, this will fur-
ther improve the accuracy of GRNs
reconstructed using single-cell data in the
future.
The incorporation of dynamic information
extracted from time series or pseudotime
(Ocone et al., 2015; Pratapa et al., 2019) is
another promising avenue to further improve
single-cell GRN reconstruction. However, not all
datasets are equally well suited to identify tem-
poral trajectories. For example, PBMCs are usu-
ally in steady state, and only after stimulation
such trajectories would appear.
Summarized, the ideal GRN reconstruction
tool can efficiently manage large amounts of sin-
gle-cell data, incorporate prior information,
model non-linear relationships and take dynamic
information into account. Early benchmark stud-
ies, performed for a limited number of methods
on rather small datasets (Jackson et al., 2019)
or on simulated data (Lukowski et al., 2017)
show that current tools usually only work well in
specific situations. As such, there is a clear need
for the development of all-round tools that work
well in every situation.
sc-eQTLGen: a federated single-
cell eQTL meta-analysis
consortium
Combining data of numerous groups increases
the resolution and power by which downstream
analyses, such as eQTL identification and per-
sonalized GRN reconstruction, can be per-
formed. Ideally, all scRNA-seq datasets should
be jointly analyzed at one centralized location.
This is particularly helpful to align each group’s
approaches for preprocessing, quality control
(QC) and cell type classification. However, it also
eases for instance benchmarking different statis-
tical and computational methods. While this con-
cept of ‘bringing the data to the algorithm’ is
preferred from an analytical perspective, it is
usually very difficult to do so when handling pri-
vacy-sensitive scRNA-seq and genotype data
from human individuals (Lloyd-Jones et al.,
2017; Yengo et al., 2018).
To overcome this, a federated approach
could be used instead, which has the aim of
‘bringing the algorithm to the data’: each partic-
ipating cohort will run the analyses themselves
(adhering to predefined criteria for preprocess-
ing and QC), and will only share summary statis-
tics that are not privacy-sensitive. Finally, one
site takes responsibility for performing the over-
all meta-analysis using these provided summary
statistics. For genome-wide association studies
this is a common strategy (Xue et al., 2018;
Luecken and Theis, 2019), and for eQTL studies
this procedure has been shown to be effective
as well (Võsa, 2018; Westra et al., 2013). In the
following sections we will expand on all steps
that have to be taken and what considerations
should be made when conducting such a feder-
ated approach for single-cell population genet-
ics studies (Figure 4).
Preprocessing, quality control
The first challenge of federated analyses is the
need to have a standardized protocol on how
each group should perform their analyses. While
such a protocol helps to ensure reproducibility
of the data analysis, it requires that all methods
and tools used have been rigorously tested
before. For scRNA-seq data such protocols are
still under development, while in other fields
such as that of genome-wide association studies,
standardized protocols have been available for
years.
Several initiatives are now being undertaken
to define best practices in the scRNA-seq field
(Tian et al., 2019). For example, Tian et al. have
compared 3913 combinations of different
scRNA-seq data analysis pipelines to define best
practices in the field (Price et al., 2006). Such
initiatives could provide the basis for defining
the optimal preprocessing, QC and cell type
classification steps for our consortium. Addition-
ally, in population-based scRNA-seq studies spe-
cial attention is required to account for ethnic
variation and population stratification (see
Box 1; Zeng and Gibson, 2019; Zhou and
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Stephens, 2012). In the event of presence of
relatedness in a given cohort, a genetic related-
ness matrix will be included in a mixed model to
account for the effect, such as in Zhou and Ste-
phens (2012); Abdelaal et al. (2019). Adjust-
ments of cohort-level genetic differences will be
made in the framework of meta-analysis using
summary statistics of the individual cohorts.
Once all protocols are established, we can har-
monize the preprocessing steps across all
groups in the consortium, such as the genome
build to use, alignment tool and sample demulti-
plexing strategy. Due to the cohort-specific
characteristics of each dataset, the QC steps
cannot be harmonized to the same extent as the
preprocessing. Nevertheless, the parameters
used for QC can be coordinated across all
groups, such as the cutoffs for number of
detected genes per cell and mitochondrial frac-
tion. Both the preprocessing and the QC do not
require exchanges of data and can be per-
formed independently.
Cell type classification
To facilitate the eQTL meta-analysis, we need to
ensure that the cell type annotations are consis-
tent across the different cohorts. To ensure
reproducibility of annotations across the differ-
ent cohorts, we will employ a classification
scheme to identify canonical cell types in each
cohort separately. Performing cell type labeling
using classification models does not only
increase the reproducibility, but also constitutes
a privacy-safe way of annotating cell types that
does not require the sharing of raw or processed
gene expression data.
Reference datasets with labeled cells, such as
those available from the Immune Cell Atlas
(http://immunecellatlas.net/) will be used to train
a classifier for automatic cell type classification in
each cohort. Our recent comparisons of single
cell classification methods showed that simple
linear models can yield good results
(Köhler et al., 2019; Wolf et al., 2019). Despite
the wide availability of reference datasets, we
expect that some cohorts will contain novel
unknown cell types or states that cannot be
identified using the trained classifier. For this,
we will use a classification scheme with a rejec-
tion option that can flag unknown cells whenever
the confidence in cell type assignment is low
(Köhler et al., 2019). The rejected cells can then
be manually annotated based on marker gene
expression.
To capitalize on the large number of cells and
individuals to be profiled in each cohort, an
unsupervised clustering approach will be used to
analyze the count matrix of each cohort, in paral-
lel to the supervised approach described earlier.
This unsupervised approach will serve two pur-
poses: (1) it will help annotate unassigned cells
by the classifier, and (2) it will allow refining the
resolution at which cells are annotated. Varying
levels of granularity of the clustering may reveal
cell types, as well as particular cell states or sub-
types. This level of granularity required to sepa-
rate particular cell states is not known a priori.
Therefore, novel unbiased approaches such as
partition based graph abstraction (Baran, 2018)
or metacells, i.e. disjoint, homogenous and
highly compact groups of cells that each exhibit
only sampling variance (Saelens et al., 2019),
provide a framework to reconcile discrete states
at different levels of granularity with continuous
cell states. These novel annotations can feed
back into an iterative online learning approach
of supervised classification models, where we
could refine cell type prediction models on the
available datasets. Once new datasets become
available within the consortium these can be
annotated based on current models and
updated labels can be used in the next round of
training. An important consideration here is to
preserve the hierarchy of cell annotations, so
that if new annotations are added to the classi-
fier, they are subclasses of existing classes. In
this way, any downstream analysis based on
older annotations remains valid at the older level
of granularity. This would yield a coherent
approach of labeling over time as the dataset
grows. For inference of continuous cell states,
we require data integration across multiple cen-
ters, as this would ensure the usage of a similar
pseudotime scale between individuals. Cur-
rently, ordering cells along pseudotime is chal-
lenging and best practices are being evaluated
(Price et al., 2006; Roshchupkin et al., 2016).
Ultimately, integrating all expression data in a
privacy-preserving manner, i.e. as gene expres-
sion matrices, will produce a dataset with
unprecedented numbers of cells. Such a
dataset allows discovery of novel rare cell types
or states using clustering approaches as
described above. This valuable dataset will then
be shared with the community through plat-
forms like the HCA data portal.
eQTL and co-expression QTL analysis
After cell type assignment, annotated gene
expression matrices can be returned to each of
the cohorts. Each cohort will then map genome-
wide cell type-specific cis- and trans-eQTLs by
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combining the cell type-specific gene expression
matrices with the privacy-sensitive bulk-assessed
genotype information using appropriate statisti-
cal models. The resulting summary-statistics can
then be safely shared without privacy-issues.
One challenge with federated eQTL analyses
is that the amount of summary statistics that
need to be shared is substantial. For instance,
when assuming there are 10 cohorts and for
each of these cohorts cells have been assigned
to 10 major cell types, a genome-wide trans-
eQTL analysis (testing the effect of 10,000,000
common SNPs on 20,000 protein coding genes
for each of the 10 cell types), where only the cor-
relation for a SNP-gene combination is stored as
a 64 bit double value, would require each cohort
to exchange 10,000,0000  20,00010 x eight
bytes = 146 terabytes of data. To overcome this
problem, several frameworks have recently been
proposed that take advantage of the fact that
these summary statistics matrices reflect the
product of a normalized genotype matrix and a
normalized gene expression matrix. For
instance, the HASE framework (Silvester et al.,
2018) recodes genotype and phenotype (i.e.
gene expression) data, along with a covariate
matrix, in such a way that privacy is ensured and
only those matrices, making up only a few giga-
bytes of data, need to be exchanged.
While protocols exist that explain how eQTL
data needs to be processed, harmonized and
QCed to perform a federated eQTL analysis
(e.g. eQTLGen used the eQTLMappingPipeline
[Võsa, 2018]), not all steps can be completed
immediately: for instance, to identify effects of
polygenic risk scores on gene expression levels
(ePRS), gene expression data first needs to be
corrected for cis-eQTL effects (Võsa, 2018).
Therefore, the full cis-eQTL meta-analysis has to
precede calculations of ePRSs. Such iterations
take considerable time and are also inconve-
nient, since it requires a lot of coordination with
each of the participating cohorts. For sc-eQTL-
Gen we will first conduct a federated, cell type-
specific cis- and trans-eQTL analysis. After this is
completed, we will proceed with a co-expression
QTL (co-eQTL) analysis. This analysis will be lim-
ited to a predefined set of genes or SNPs, such
as the SNP-gene combinations extracted from
the identified cis- and trans-eQTLs or the SNPs
located within open chromatin regions that
show high interindividual variability, as otherwise
trillions of statistical tests have to be conducted
(e.g. in van der Wijst et al., 2018a: 7975 vari-
able genes * 7975 variable genes * 4,027,501
SNPs (MAF 0.1) = 256,151,580,788,125 tests).
Finally, all these results will be combined to
reconstruct personalized, cell type-specific
GRNs. This multi-step approach will require us
to go back and forth between the different
cohorts at least twice. Therefore, easy-to-use
analysis scripts that can be run efficiently on dif-
ferent high-performance cluster infrastructures
are essential to limit the amount of hands-on
time.
Gene regulatory network reconstruction
Finally, the scRNA-seq data will be used to
reconstruct GRNs. Two strategies will be
explored in the context of sc-eQTLGen. The first
approach makes use of the large number of bulk
RNA-seq datasets for specific cell types that are
available in public RNA-seq repositories
(Leinonen et al., 2011; Langfelder and Hor-
vath, 2008). Using this publicly available bulk
RNA-seq data, reference co-expression networks
will be constructed using cell type-specific data.
Subsequently, scRNA-seq data will be used to
implement directionality and specify the connec-
tions in the network that are affected by specific
contexts (La Manno et al., 2018). The second
approach will directly use scRNA-seq data to
build cell type-specific GRNs, thereby enabling
to immediately take the context-specificity into
account. However, the number of genes that can
confidently be taken into account by this second
approach may be lower due to the sparsity of
scRNA-seq data. For both strategies, we will
make use of prior information (e.g. ATAC-seq
data [Qin et al., 2014], TF binding information),
dynamic information (e.g. information extracted
from time series data (Ocone et al., 2015),
pseudotime (Pratapa et al., 2019) in combina-
tion with RNA velocity (Qiu, 2018; Fiers et al.,
2018) and experimental validation (e.g. pertur-
bation experiments [Gate, 2019; Aibar et al.,
2017]) to go from a co-expression to a gene
regulatory network. Before implementation, the
additional benefit of using such information,
extracted from either bulk or single-cell data
(Aibar et al., 2017; Andrews and Hemberg,
2018), and using gene expression imputation
(Aibar et al., 2017; Iacono et al., 2019) will be
assessed. We expect that the optimal strategy
will depend on the amount of available bulk
data and prior information that is available for a
particular cell type. We will extract this prior
information from existing large-scale efforts,
such as ENCODE (Wang et al., 2018) and BLUE-
PRINT (Chen et al., 2016). Additionally, we will
make use of single-cell information beyond gene
expression levels that is or will be collected
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within subsets of cohorts within the consortium,
including information on chromatin accessibility
(Lareau et al., 2019; Hayashi et al., 2018) and
expression of enhancers RNAs (Kouno et al.,
2019; Lin et al., 2016).
Additionally, recent advances have made it
possible to measure multi-omics data from the
very same cell (Moignard et al., 2015;
Sverchkov and Craven, 2017). However, cur-
rent approaches are very time- and cost-con-
suming, and therefore limited to only a few
hundred cells. As such, currently, this type of sin-
gle-cell multi-omics data is of limited use for
reconstructing personalized GRNs. Nevertheless,
as single-cell multi-omics approaches mature,
this combined information of gene expression
and additional data layers has the potential to
improve GRN inference beyond correlating sep-
arate omics layers and allows for direct measure-
ments instead.
Once reconstructed, these GRNs can be used
to determine how for example, genetic differen-
ces or disease status change the architecture of
the network. These networks consist of nodes,
representing genes, that are connected through
edges, representing the relationship between
genes. The context-specific changes in the net-
work can be identified on different levels, such
as on the level of individual edges or nodes,
topological properties of individual nodes, such
as their connectivity (degree) or module mem-
bership (GTEx Consortium, 2015), subnetwork
properties, such as the existence and size of
modules, or global topological properties, such
as degree distribution (Figure 3). Comparing
topological features such as node degree to
genotypes may identify polymorphisms altering
the function of master regulators (highly con-
nected ‘hub’ genes). Interestingly, implementa-
tion of network information was shown to be
complementary to the identification of eQTLs;
using this network information, novel SNPs were
identified that could not be identified through
single- or multi-tissue eQTL analyses of GTEx
(Clark et al., 2018). This clearly shows the com-
plementarity of both eQTL and network-based
analyses for understanding the impact of genetic
variation.
Ultimately, CRISPR perturbations will be cou-
pled to scRNA-seq to validate or improve recon-
structed GRNs. To optimize the number of
perturbations required for extracting the most
useful information from such experiments, an
iterative approach will be taken that feeds back
the experimental data to the GRN. This
approach will make use of active machine
learning to select those perturbations that are
required to further improve the model (Ud-
Dean and Gunawan, 2016; Aguet, 2019).
These well validated, personalized and context-
specific GRNs will provide us with a better
understanding of disease and can be the starting
point of applying this knowledge for precision
medicine in the future.
Future clinical implications
The goal of the sc-eQTLGen consortium is to
identify how genetic and environmental factors
interact to affect gene expression in the context
of both health and disease. With ever increasing
sample sizes, eQTLs have now been detected
for almost every gene (GTEx Consortium, 2017;
Võsa, 2018). It is likely this will become even
more pronounced through our initiative in which
we will study many different cell types and con-
texts, and pose the question to what extent
extensive eQTL maps will help to better under-
stand disease. For cis-eQTLs this will not be
straightforward: although it is known that dis-
ease-associated SNPs are enriched for showing
cis-eQTL effects, this enrichment is quite modest
(Zhernakova et al., 2017; Liu et al., 2019). It is
therefore not sufficient to simply look up and
catalogue which disease-associated SNPs show
which cell type- and context-specific eQTL
effects, since this can lead to incorrect infer-
ences on the likely causal gene(s) per locus
(Giambartolomei et al., 2014). To partly over-
come this, several colocalization and Mendelian
randomization approaches have been published
that help to better infer likely causal genes
(Gusev et al., 2016; Porcu et al., 2019;
Mancuso et al., 2019; Kemp, 2019). Once
these methods are able to account for multiple
cell type- and context-dependent, causal regula-
tory variants per locus, we expect increased sta-
tistical power to prioritize causal genes.
Additionally, we envision that such methods in
conjunction with our cell type- and context-spe-
cific eQTL maps will help to determine which
genetic variants have pleiotropic effects, affect-
ing the expression levels of several genes in mul-
tiple cell types and conditions.
Nevertheless, we expect that most statistical
power to pinpoint causal genes will be gained
through the other goals of the sc-eQTLGen con-
sortium: the reconstruction of cell type-specific
gene regulatory networks (expected by the end
of 2022), the mapping of cell type-specific trans-
eQTLs and co-expression QTLs (expected by the
end of 2021). These efforts will enable us to
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ascertain how the prioritized cis-eQTL genes
(expected by the end of 2021) work together.
Moreover, it permits us to study the effect of all
disease-associated SNPs of a particular disease
in a gene network structure, which helps priori-
tizing the key disrupted genes and pathways in
that disease. In line with recent findings of the
eQTLGen consortium that applied eQTL analysis
in 31,684 bulk samples, we expect that the
(majority of) causal genes within disease-associ-
ated loci will converge onto only a few key path-
ways per disease.
One strategy to identify those key driver
genes is to consider all associated variants for a
specific disease jointly, and ascertain whether
most of these variants show (small) downstream
effects on an overlapping set of downstream
genes. We recently showed proof-of-concept in
eQTLGen that this holds for independent sys-
temic lupus erythematosus (SLE)-associated
SNPs: many of these variants show downstream
trans-eQTL effects on genes involved in the type
I interferon pathway (Võsa, 2018), indicating an
important role for this pathway in SLE develop-
ment. Recently, success has been reported of a
type I interferon-targeted therapy in SLE
patients (Astle et al., 2016), highlighting the
value of using trans-eQTLs for identifying key
genes and pathways that are amenable for phar-
maceutical intervention. We expect that our sin-
gle-cell eQTL initiative will aid such analyses
substantially: by performing large-scale eQTL
mapping in specific cell types that are in a spe-
cific cellular state or are exposed to a particular
stimulus, we will be able to more accurately
determine where and when these downstream
effects manifest. Moreover, single-cell studies
will also help to overcome the problem associ-
ated with cell type composition differences
across individuals in bulk-based eQTL studies:
many variants exist that affect the proportion of
specific cell types that for instance circulate in
blood (Vieira Braga et al., 2019). If this is not
fully accounted for, trans-eQTLs will be identi-
fied in genes that are specifically expressed in
such cell types in bulk analyses. Single-cell stud-
ies allow us to distinguish between effects of
genetic variants on cell type composition and
effects on intracellular gene expression levels.
Therefore, we expect scRNA-seq data will be
vital to gain insight into the downstream conse-
quences of disease-associated genetic variants,
and to identify the key pathways and genes that
drive disease.
Altogether, we expect these approaches will
provide us with the information required to
reveal new targets for disease prevention and
treatment (Figure 5). For example, a novel sub-
set of tissue-resident memory T cells has recently
been identified in the setting of asthma using
scRNA-seq (Schork, 2015). This study also
showed that mostly T helper 2 cells are dominat-
ing the cell-cell interactions in the asthmatic air-
way wall, whereas in healthy controls mostly
epithelial and mesenchymal cell types are com-
municating with each other. Integration of the
gene expression of this asthma-associated cell
type with asthma-associated genetic risk variants
would further increase our understanding of the
disease and such knowledge would greatly
accelerate the development of personalized/pre-
cision treatments in the future. It is this informa-
tion about how genes interact differently
between individuals as a function of their genetic
predisposition that will be obtained through the
results of our consortium (Figure 5). One of the
major benefits of such personalized treatments
is in prescribing the correct drug based on the
individual (mechanism that underlies) susceptibil-
ity to disease. Currently only between 4% and
25% of the people respond to commonly pre-
scribed drugs (Mukherjee and Topol, 2002),
showing the need to better predict drug respon-
siveness and thereby avoid unnecessary expo-
sure to side-effects.
This high interindividual variability in drug
response is a consequence of genetic and envi-
ronmental exposure differences between indi-
viduals, which can result in differences in drug
metabolism, absorption and excretion (pharma-
codynamics) (Johnson et al., 2012). For exam-
ple, a variant in the CYP2C19 gene changes the
response to the anti-blood clotting drug clopi-
dogrel. The CYP2C19 gene encodes for an
enzyme in the bioactivation of the drug.
CYP2C19 poor metabolizers were shown to
exhibit higher cardiovascular event rates after
acute coronary syndrome, or percutaneous coro-
nary intervention, as compared to patients with
normal CYP2C19 function (Tigchelaar et al.,
2015).
While previous efforts have mainly focused on
pharmacodynamic variation, recent single-cell
analyses have revealed that gene-gene interac-
tions can also be changed by genetic (van der
Wijst et al., 2018a) and environmental variation
(Cuomo et al., 2020). For example, two closely
related SNPs (linkage disequilibrium R2 = 0.92)
affected both gene-gene interactions (RPS26
and RPL21) (van der Wijst et al., 2018a) and
gene-environment interactions (RPS26 and the
respiratory status of the cell) (Cuomo et al.,
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2020). This shows that gene regulatory network
changes may underlie part of the interindividual
variation in drug responsiveness. However, such
effects have never been studied in detail before
and the extent to which such interactions affect
drug responsiveness are unknown. The sc-eQTL-
Gen consortium is able to study both how gene-
gene interactions and gene-environment interac-
tions are affected by genetic variation, giving
insight into where and when they occur. Impor-
tantly, the applied methodologies will be easily
transferable to single-cell data that is collected
in other cell types and disease context through
other large-scale efforts (Regev et al., 2017)
(https://lifetime-fetflagship.eu). Moreover, sev-
eral partners within our consortium have gener-
ated scRNA-seq data in cohorts with extensive
information on individuals’ health records and
drug usage (e.g. the Lifelines Deep cohort [Hea-
ton, 2019] and the OneK1K cohort). With such
information, we will be able to validate the link
between changes in the gene regulatory net-
work and the drug responsiveness of an individ-
ual. This allows us to determine the predictive
value of gene networks for determining respon-
siveness of specific drugs and the applicability of
such networks in precision medicine.
As such, the sc-eQTLGen consortium will not
only increase our basic knowledge about the
contribution of genetics in gene expression and
its regulation, but will also be a valuable
resource for drug target identification and vali-
dation. To increase the impact of this work, all
code, guidelines and summary statistics (includ-
ing all non-significant results) will become freely
available to the community through the sc-
eQTLGen website (https://eqtlgen.org/single-
cell.html). For any additional information, please
visit the contact page (https://eqtlgen.org/con-
tact.html).
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Porcu E, Rüeger S, Lepik K, Santoni FA, Reymond A,
Kutalik Z, eQTLGen Consortium, BIOS Consortium.
2019. Mendelian randomization integrating GWAS and
eQTL data reveals genetic determinants of complex
and clinical traits. Nature Communications 10:3300.
DOI: https://doi.org/10.1038/s41467-019-10936-0,
PMID: 31341166
Pratapa A, Jalihal AP, Law JN, Bharadwaj A, Murali TM.
2019. Benchmarking algorithms for gene regulatory
network inference from single-cell transcriptomic data.
bioRxiv. DOI: https://doi.org/10.1101/642926
Price AL, Patterson NJ, Plenge RM, Weinblatt ME,
Shadick NA, Reich D. 2006. Principal components
analysis corrects for stratification in genome-wide
association studies. Nature Genetics 38:904–909.
DOI: https://doi.org/10.1038/ng1847, PMID: 16862161
Qin J, Hu Y, Xu F, Yalamanchili HK, Wang J. 2014.
Inferring gene regulatory networks by integrating
ChIP-seq/chip and transcriptome data via LASSO-type
regularization methods. Methods 67:294–303.
DOI: https://doi.org/10.1016/j.ymeth.2014.03.006,
PMID: 24650566
Qiu X. 2018. Towards inferring causal gene regulatory
networks from single cell expression measurements.
bioRxiv. DOI: https://doi.org/10.1101/426981
van der Wijst et al. eLife 2020;9:e52155. DOI: https://doi.org/10.7554/eLife.52155 19 of 21
Feature Article Science Forum The single-cell eQTLGen consortium
Raj A, Peskin CS, Tranchina D, Vargas DY, Tyagi S.
2006. Stochastic mRNA synthesis in mammalian cells.
PLOS Biology 4:e309. DOI: https://doi.org/10.1371/
journal.pbio.0040309, PMID: 17048983
Regev A, Teichmann SA, Lander ES, Amit I, Benoist C,
Birney E, Bodenmiller B, Campbell P, Carninci P,
Clatworthy M, Clevers H, Deplancke B, Dunham I,
Eberwine J, Eils R, Enard W, Farmer A, Fugger L,
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López C, Jonker MR, Affleck K, Palit S, Strzelecka PM,
Firth HV, Mahbubani KT, et al. 2019. A cellular census
of human lungs identifies novel cell states in health
and in asthma. Nature Medicine 25:1153–1163.
DOI: https://doi.org/10.1038/s41591-019-0468-5,
PMID: 31209336
van der Wijst et al. eLife 2020;9:e52155. DOI: https://doi.org/10.7554/eLife.52155 20 of 21
Feature Article Science Forum The single-cell eQTLGen consortium
Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar
K, Fletcher J, Griesbeck M, Butler A, Zheng S, Lazo S,
Jardine L, Dixon D, Stephenson E, Nilsson E,
Grundberg I, McDonald D, Filby A, Li W, De Jager PL,
Rozenblatt-Rosen O, et al. 2017. Single-cell RNA-seq
reveals new types of human blood dendritic cells,
monocytes, and progenitors. Science 356:eaah4573.
DOI: https://doi.org/10.1126/science.aah4573,
PMID: 28428369
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